Choate Investment Advisors’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Hold |
10,000
| – | – | ﹤0.01% | 418 |
|
|
2025
Q1 | $115K | Hold |
10,000
| – | – | ﹤0.01% | 390 |
|
|
2024
Q4 | $84.7K | Hold |
10,000
| – | – | ﹤0.01% | 399 |
|
|
2024
Q3 | $116K | Hold |
10,000
| – | – | ﹤0.01% | 380 |
|
|
2024
Q2 | $118K | Hold |
10,000
| – | – | ﹤0.01% | 376 |
|
|
2024
Q1 | $119K | Hold |
10,000
| – | – | ﹤0.01% | 403 |
|
|
2023
Q4 | $123K | Hold |
10,000
| – | – | ﹤0.01% | 373 |
|
|
2023
Q3 | $96.3K | Hold |
10,000
| – | – | ﹤0.01% | 377 |
|
|
2023
Q2 | $90K | Buy |
+10,000
| New | +$90K | ﹤0.01% | 303 |
|